Background The human gut microbiota has profound influence on host metabolism and
immunity. This study characterized the fecal microbiota in patients with nonalcoholic …

Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease,
represents a spectrum of nonalcoholic hepatic steatosis, nonalcoholic steatohepatitis, liver …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease
worldwide, affecting approximately 25% of the population, and is quickly becoming the …

Background Recent research showed that probiotics treatment may reduce insulin
resistance, regulate lipid metabolism, raise liver enzyme levels, and ameliorate inflammation …

From their paper it is apparent that most promises still derive from a relevant number of
studies conducted in different NAFLD animal models. When interpreting data obtained in …

Background Nonalcoholic fatty liver disease (NAFLD) is a multifactorial disorder that can
progress to fibrosis. Several dietary patterns have been associated with histological features …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising worldwide, and it is
estimated that approximately one billion individuals may be afflicted with NAFLD globally [1 …

Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome.
Its prevalence increases with increasing rates of obesity, insulin resistance, and diabetes …

© HepatoBiliary Surgery and Nutrition. All rights reserved. HepatoBiliary Surg Nutr 2021; 10
(1): 136-138| http://dx. doi. org/10.21037/hbsn-20-760 article by Ratjen et al.(4), only one …

The pathogenesis of non-alcoholic fatty liver disease (NAFLD), the most common global
liver disease, is complex as multiple parallel hits drive this disorder. Whereas lipotoxicity …